Integer Holdings Equity Compensation Plan
A guide to thinking through your Equity Compensation as a Integer Holdings employee.
By Zac Murphy, CFA charterholder, CFP® professional. Last reviewed June 30, 2026.
Equity compensation in healthcare varies widely by subsector. Large pharmaceutical companies and medical device manufacturers commonly grant RSUs and performance-based shares, often tied to clinical or commercial milestones. Biotech grants can include performance conditions linked to drug development progress. Equity is generally less common at hospitals and health systems, which are often nonprofit.
Common questions
How do performance-based equity grants typically work?
Performance-based grants vest only if specified conditions are met, such as clinical trial outcomes, regulatory approvals, revenue targets, or relative stock performance. The timing and amount of vested shares depend on whether and when those conditions are achieved, which can introduce more uncertainty than time-based vesting.
How are RSU vests taxed for pharma and biotech employees?
When RSUs vest, the value of the shares is generally treated as ordinary income, and employers typically withhold a portion of the shares to cover tax liability. The default withholding rate may not match an employee's actual marginal tax rate, particularly for senior roles where total compensation pushes into higher brackets.
What considerations come up around concentration in biotech stock?
Biotech stock prices can move sharply in response to clinical trial results and regulatory decisions, which makes concentration in a single biotech employer's stock different from concentration in a more diversified large-cap. Factors that come up include the share of net worth in company stock, time horizon, and tolerance for binary outcome risk.
Equity decisions in pharma and biotech involve tax planning, performance-condition mechanics, and concentration management. A financial advisor familiar with equity compensation can help work through the specifics.
Common challenges
RSUs, ISOs, and NSOs are taxed differently. RSUs are taxed as income at vesting. NSOs are taxed at exercise. ISOs can qualify for capital gains treatment but trigger AMT. Getting this wrong is expensive.
Concentration risk is real. Vesting grants plus ESPP plus 401(k) company stock can mean most of your wealth rides on one company. Diversifying takes planning around tax, blackout windows, and 10b5-1 considerations.
Exercise timing is a real decision. Early exercise, holding for long-term gains, or selling at vest each have tradeoffs across tax, cash flow, and risk. The right choice depends on the stock, your tax picture, and your other goals.
If any of these apply to your situation, the contact info below is the fastest way to start a conversation.
Have any questions about your equity compensation? Reach out to us by email or phone at the contact info below.
Email: [email protected]
Phone: (904) 654-3336
More guides for Integer Holdings
This page is for educational purposes only and does not constitute investment, tax, or legal advice.